Skip to main content

Homepage

Latest News

IMI launches final IMI2 Calls for proposals

Tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, clinical trial data, and patient adherence are the topics proposed for IMI’s next Calls for proposals, which will be launched on 23 June. Registration is open for the webinars, which will run from 15 to 30 June.

/news-events/press-releases/imi-launches-final-imi2-calls-proposals
/news-events/press-releases/imi-launches-final-imi2-calls-proposals

New tools to help identify potential targets in autoimmune diseases

New tools to help identify potential targets in autoimmune diseases  more

An open letter in response to the GHA/CEO report on IMI

An open letter in response to the GHA/CEO report on IMI  more

Meet the IMI projects already helping to fight COVID-19

Meet the IMI projects already helping to fight COVID-19  more

 

 

IMI BROCHURE HIGHLIGHTS PROJECT SUCCESSES

IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of our projects in our new brochure, and learn how we are 'Carrying the torch for medical innovation'.

 more

dna.jpg

 

 

 

WATCH IMI video

Carrying the torch for medical innovation

Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments. Watch our video and share it!